These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5868038)

  • 1. [The cholesterol-decreasing effect of atromid. A clinical study].
    Mogensen EF
    Ugeskr Laeger; 1965 Oct; 127(41):1290-3. PubMed ID: 5868038
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of clofibrate on raised serum lipid levels.
    Smith RB; Prior IA; Cooke NJ
    N Z Med J; 1968 Oct; 68(437):231-4. PubMed ID: 5247681
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
    De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
    Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of platelet stickiness tests during an atromid-S trial.
    O'Brien JR; Heywood JB
    Thromb Diath Haemorrh; 1966 Dec; 16(3):768-77. PubMed ID: 5996687
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clofibrate with or without androsterone in the treatment of hypercholesteremia].
    Stenbaek O
    Tidsskr Nor Laegeforen; 1967 Jun; 87(11):1051-3. PubMed ID: 6047508
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action mechanism and clinical success of Regelan (Clofibrate)].
    Fitzgerald JD
    Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
    [No Abstract]   [Full Text] [Related]  

  • 7. A controlled trial of Atromid therapy in exudative diabetic retinopathy.
    Cullen JF; Ireland JT; Oliver MF
    Trans Ophthalmol Soc U K (1962); 1964; 84():281-95. PubMed ID: 5227423
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy of essential hypercholesteremia?].
    Schettler G
    Dtsch Med Wochenschr; 1968 Sep; 93(37):1779. PubMed ID: 5681549
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of atromide on some indices of the lipid metabolism in hypercholesterinemic patients].
    Baranova LV
    Kardiologiia; 1965; 5(4):65-6. PubMed ID: 5880736
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of hypercholesteremia].
    Zöllner N
    Med Klin; 1968 Aug; 63(35):1402. PubMed ID: 5687771
    [No Abstract]   [Full Text] [Related]  

  • 11. Atromid-S for the reduction of plasma lipids.
    Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
    [No Abstract]   [Full Text] [Related]  

  • 12. Clofibrate and androsterone effect on serum lipids.
    Orgain ES; Bogdonoff MD; Cain C
    Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
    [No Abstract]   [Full Text] [Related]  

  • 13. [Atromid].
    Borchgrevink CF
    Tidsskr Nor Laegeforen; 1967 Mar; 87(5):334. PubMed ID: 6039533
    [No Abstract]   [Full Text] [Related]  

  • 14. [The therapeutic use of CPIB in pathological increase of the lipid constituents of the blood].
    Cloarec M; Cottet J; Etienne J; Loeper J
    Sem Ther; 1965 Nov; 41(9):499-500. PubMed ID: 5877602
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV
    Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of clofibrate with androsterone (atromid) and without androsterone (atromid-S) on blood platelets and lipids in ischaemic heart disease.
    Carson P; McDonald L; Pickard S; Pilkington T; Davies B; Love F
    Br Heart J; 1966 May; 28(3):400-3. PubMed ID: 5936972
    [No Abstract]   [Full Text] [Related]  

  • 17. A three-year trial of atromid therapy in exudative diabetic retinopathy.
    Duncan LJ; Cullen JF; Ireland JT; Nolan J; Clarke BF; Oliver MF
    Diabetes; 1968 Jul; 17(7):458-67. PubMed ID: 4875170
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of atromid S on certain plasma lipid indexes].
    Hanzlik J
    Pol Tyg Lek; 1967 Jan; 22(1):9-11. PubMed ID: 6038112
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 20. Divergent effects in the treatment of hyperlipemia.
    Slowe IA; Carter AC; Feldman EB
    Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.